Jennifer Kayden Lee insider trades
Open-market stock purchases and sales by Jennifer Kayden Lee, EVP, Head of North America at Rhythm Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 7, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 13, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Sold | $8.9M |
| Aug 13, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Aug 13, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 11, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 11, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 1, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 1, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 1, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 1, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Sold (not open market) | $1M |
| Feb 1, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 1, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- RYTM Rhythm Pharmaceuticals, Inc: 32 sales, last Aug 13, 2026
Get free alerts when Jennifer Kayden Lee files a new trade →